Gapping up
In reaction to strong earnings/guidance: WG +1.7%, FCEL +1.3%, RCI +1.2%, MMM +1.1%
M&A news: TLM +49% (Repsol (REPYY) to acquire Talisman Energy for $8.00 per common share in all-cash transaction), IHG +1.1% (agreed to acquire Kimpton Hotels & Restaurants for $430 mln in cash)
Select metals/mining stocks trading higher: VALE +4.7%, IAG +4.3%, GG +3.9%, KGC +3.7%, GDX +3.5%, SLW +3.4%, RIO +2.9%, ABX +2.8%, HL +2.8%, NEM +2.6%, GLD +1.6%, MT +1.6%, SLV +1.2%, BHP +1.2%
Other news: BLRX +19.6% ( announced that it has entered into a multi-year strategic collaboration agreement with Novartis Pharma (NVS)), STRI +16.5% (announced closing of sale of controlling interest to Zhenfa Energy Group; declared special dividend of $0.85 per share; increased size of Board of Directors), LADR +10.7% (announced that it is commencing the steps necessary to elect Real Estate Investment Trust status with an expected effective date of January 1, 2015), PRTA +9% (announced that the FDA granted Fast Track designation to NEOD001, a novel monoclonal antibody for the potential treatment of AL amyloidosis), AUY +7.4% (announced 'significant' new discoveries at Chapada and El Penon; discoveries improve operational outlook), RSH +5.1% (entered into an agreement for advisory and interim management services with FTI Consulting), IMN +4.7% (Clinton Group intends to nominate three candidates for the Imation Board of Directors), TS +4.1% (still checking), SNE +3.1% (issues press release on measure taken surrounding cyber attacks), PKI +1.4% (FDA approved marketing of the EnLite Neonatal TREC Kit to help detect Severe Combined Immunodeficiency), BA +1.2% (increased share repurchase authorization to $12 bln and raised dividend by 25%).
Analyst comments: SPWR +1.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley), SAVE +1.3% (upgraded to Outperform from Mkt Perform at Raymond James), RAD +1.2% (upgraded to Buy from Neutral at UBS), GRUB +0.8% (upgraded to Buy from Neutral at Goldman), FBC +0.6% (upgraded to Outperform from Mkt Perform at Keefe Bruyette), RXN +0.5% (initiated with a Buy at KeyBanc Capital Mkts)
In reaction to strong earnings/guidance: WG +1.7%, FCEL +1.3%, RCI +1.2%, MMM +1.1%
M&A news: TLM +49% (Repsol (REPYY) to acquire Talisman Energy for $8.00 per common share in all-cash transaction), IHG +1.1% (agreed to acquire Kimpton Hotels & Restaurants for $430 mln in cash)
Select metals/mining stocks trading higher: VALE +4.7%, IAG +4.3%, GG +3.9%, KGC +3.7%, GDX +3.5%, SLW +3.4%, RIO +2.9%, ABX +2.8%, HL +2.8%, NEM +2.6%, GLD +1.6%, MT +1.6%, SLV +1.2%, BHP +1.2%
Other news: BLRX +19.6% ( announced that it has entered into a multi-year strategic collaboration agreement with Novartis Pharma (NVS)), STRI +16.5% (announced closing of sale of controlling interest to Zhenfa Energy Group; declared special dividend of $0.85 per share; increased size of Board of Directors), LADR +10.7% (announced that it is commencing the steps necessary to elect Real Estate Investment Trust status with an expected effective date of January 1, 2015), PRTA +9% (announced that the FDA granted Fast Track designation to NEOD001, a novel monoclonal antibody for the potential treatment of AL amyloidosis), AUY +7.4% (announced 'significant' new discoveries at Chapada and El Penon; discoveries improve operational outlook), RSH +5.1% (entered into an agreement for advisory and interim management services with FTI Consulting), IMN +4.7% (Clinton Group intends to nominate three candidates for the Imation Board of Directors), TS +4.1% (still checking), SNE +3.1% (issues press release on measure taken surrounding cyber attacks), PKI +1.4% (FDA approved marketing of the EnLite Neonatal TREC Kit to help detect Severe Combined Immunodeficiency), BA +1.2% (increased share repurchase authorization to $12 bln and raised dividend by 25%).
Analyst comments: SPWR +1.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley), SAVE +1.3% (upgraded to Outperform from Mkt Perform at Raymond James), RAD +1.2% (upgraded to Buy from Neutral at UBS), GRUB +0.8% (upgraded to Buy from Neutral at Goldman), FBC +0.6% (upgraded to Outperform from Mkt Perform at Keefe Bruyette), RXN +0.5% (initiated with a Buy at KeyBanc Capital Mkts)